The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Albumin component of nab-paclitaxel and skin toxicities in Chinese breast cancer patients.
Xi-Chun Hu
No relevant relationships to disclose
Lichen Tang
No relevant relationships to disclose
Biyun Wang
No relevant relationships to disclose
Si Sun
No relevant relationships to disclose
Jian Zhang
No relevant relationships to disclose
Zhen Jia
No relevant relationships to disclose
Yunhua Lu
No relevant relationships to disclose
Genhong Di
No relevant relationships to disclose
Shao Zhimin
No relevant relationships to disclose